Marquette Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Marquette Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$442	–	812
2025 Q4	$442	Buy	+2	New	+$323	﹤0.01%	684

Marquette Asset Management's CDTX Position: Q1 2026 in Review

Marquette Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2 shares — an estimated $442 sold.

Marquette Asset Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $442 in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Marquette Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Marquette Asset Management sold 2 Cidara Therapeutics shares in Q1 2026, an estimated $442.
Marquette Asset Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Marquette Asset Management's Cidara Therapeutics position peaked at $442 in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Marquette Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.